Tag Archives: Geodon

Information about Alzheimer’s Disease for Patients and Families

Alzheimer’s disease is the most common and well-known form of degenerative dementia. By definition, dementia is a syndrome, a cluster of symptoms, of impaired memory and cognition. Dementia is a cognitive disorder that impairs an individual’s memory and ability for reasoning, awareness, and judgment. Cognitive impairment in Alzheimer’s disease may involve disturbance of language (aphasia),… Read More »

Schizophrenia: Current Therapies

Etiology and Pathophysiology Schizophrenia has varied and ominous symptoms that generally begin in late adolescence or early adulthood and usually continue throughout life. The diagnostic criteria for schizophrenia have evolved over the past 20 years based on the different iterations of the Diagnostic and Statistical Manual of Mental Disorders and the International Classification of Diseases.… Read More »

Schizophrenia: Atypical Antipsychotics

Many atypical antipsychotics are available. In addition to those reviewed in the following sections, atypical agents include perospirone (Sumitomo’s Lullan) and zotepine (Fujisawa’s Lodopin, Aventis’s Nipolept, Orion Pharma’ s Zoleptil, generics). These drugs are not discussed in detail here because their mechanisms of action are similar to those of other atypical agents, they are launched… Read More »

Schizophrenia: Serotonin-Dopamine Antagonists

Serotonin-dopamine antagonists, together with dopamine partial agonists, are considered atypical antipsychotics. serotonin-dopamine antagonists have been used for the treatment of schizophrenia since the early 1990s, and currently marketed serotonin-dopamine antagonists include Novartis’s clozapine (Clozaril/Leponex, generics), Janssen’s risperidone (Risperdal), Eli Lilly’s olanzapine (Zyprexa), AstraZeneca’s quetiapine (Seroquel), and Pfizer’s ziprasidone (Geodon/Zeldox). TABLE . Emerging Therapies in Development… Read More »

Dissociative [Conversion] Disorders

Description of Medical Condition A sudden change in state of consciousness, identity, motor behavior, thoughts, feelings and perception of external reality to such an extent that these functions do not operate congruently. Many pathologic symptoms can be found, but the patient experiences dysphoria, suffering, and maladaptive functioning. Disorders include: • Dissociative amnesia • Dissociative fugue… Read More »

Changing Views of Schizophrenia and Antipsychotic Agents

In the years following the introduction of the first antipsychotic drugs (the mid-1950s), their most clinically salient effect was suppression of the symptoms of acute psychosis, including delusions, hallucinations, thought disorder, agitation, and gross disorganization. The past several years of research on the outcome of pharmacotherapy for schizophrenia have seen an emphasis on the domains… Read More »

Introduction To Atypical Antipsychotics

This section deals specifically with the use of atypical antipsychotics currently in use in the United States. In less than a decade, atypical antipsychotics have become the dominant force in the treatment of adult and childhood psychosis. As a result of this rapid change, the typical antipsychotics have been progressively relegated to the sidelines of… Read More »

Personality Disorders

Description of Medical Condition A group of conditions, with onset at or before adolescence, characterized by enduring patterns of maladaptive and dysfunctional behavior that deviate markedly from one’s culture and social environment leading to functional impairment and distress to the individual, coworkers and the family. These behaviors are perceived by the patient to be “normal”… Read More »

Chronic Illness: Current Therapies

The main goal of bipolar disorder drug treatment is to establish euthymia (stable mood with a persistent sense of well-being) without inducing mania or rapid cycling (i.e., four or more mood episodes in a 12-month period). For this reason, drug treatment usually consists of an agent or, more frequently, combinations of agents that exert both… Read More »

Antipsychotic Drug Ziprasidone (Geodon)

Information About Antipsychotic Drug Ziprasidone (Geodon) for Patients and Families Ziprasidone (Geodon) is an antipsychotic drug used in the treatment of psychotic disorders, including schizophrenia, schizoaffective disorder and psychotic depression, and acute mania in bipolar disorder. Ziprasidone is a second-generation antipsychotic, a new class of medicines with actions different from those of the older, first-generation… Read More »